“Billionaire Stanley Druckenmiller Bought This Biotech Stock That Has Surged 400%. Is It Still a Buy?”
August 28, 2026
“…One notable example of Druckenmiller’s risk-taking is his investments in clinical-stage biotech stocks. In the first quarter of 2026, his Duquesne Family Office initiated a new stake in Revolution Medicines (NASDAQ: RVMD) worth $30.7 million at the end of Q1…
Over the last 12 months, Revolution Medicines has surged by more than 400%. Is this high-flying biotech stock still a buy?…”
In my opinion medical stocks are more risky than other stocks. Just be aware of that.